Asian American Medical Group (ASX:AJJ) 3-Year EBITDA Growth Rate : 34.10% (As of Feb. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Asian American Medical Group 3-Year EBITDA Growth Rate?

Asian American Medical Group's EBITDA per Share for the six months ended in Feb. 2023 was A$0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 34.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Asian American Medical Group was 34.10% per year. The lowest was -88.00% per year. And the median was 3.10% per year.

Competitive Comparison of Asian American Medical Group's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Asian American Medical Group's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asian American Medical Group's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Asian American Medical Group's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Asian American Medical Group's 3-Year EBITDA Growth Rate falls into.

Asian American Medical Group 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Asian American Medical Group (ASX:AJJ) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Asian American Medical Group 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Asian American Medical Group's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Asian American Medical Group (ASX:AJJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Asian American Medical Group Ltd (ASX:AJJ) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

6A Napier Road, Gleneagles Hospital Annexe Block Number 02-36A/36B/37, Singapore, SGP, 258500

Website

https://www.aamg.co

Asian American Medical Group Ltd engages in the provision of specialized medical services. It operates through the following segments: Liver; Healthcare Management and Consultancy; Multi-Specialty; and Healthcare Real Estate. The Liver segment is engaged in the provision of medical consultation and services in hepatology and related fields. The Multi-specialty segment includes the provision of multi-specialty medical consultation and services in the medical pilot zone in Boao, Hainan cater to the healthcare needs of China. It provides healthcare management and consultancy services. It is also into the development of real estate projects. The firm generates the majority of its revenue from the Liver segment. Geographically it generates the vast majority of its revenue from Singapore.

Asian American Medical Group (ASX:AJJ) Headlines

No Headlines